This brand name is authorized in Austria, Australia, Brazil, Cyprus, Spain, Croatia, Ireland, Israel, Malta, Mexico, Netherlands, Romania, Tunisia, United Kingdom, South Africa
The drug SAFLUTAN contains one active pharmaceutical ingredient (API):
|
1
Tafluprost
UNII 1O6WQ6T7G3 - TAFLUPROST
|
|
Tafluprost is a fluorinated analogue of prostaglandin F2α. Tafluprost acid, the biologically active metabolite of tafluprost, is a highly potent and selective agonist of the human prostanoid FP receptor. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| SAFLUTAN Eye drops, solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| S01EE05 | Tafluprost | S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EE Prostaglandin analogues |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 2748P, 2755B |
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 556717110001517, 556717110001607 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 70063 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 158690, 373807, 377205 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 31005, 36899 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 7010 |
| Country: MT | Medicines Authority | Identifier(s): AA1068/00202, MA1068/00201 |
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 241M2014 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 167614, 93408 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W62677001, W62677002, W65332001, W65332002, W65332003, W65332004 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 18583021 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 45/15.4/0710 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
